Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joel Lewis currently holds 776,260 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel Lewis has been a net seller of GALT stock. They have purchased $79.5K and sold $388.5K worth of shares.
Joel Lewis's most recent insider trade was on Jan 5, 2026, when they purchased 56,332 shares at $3.88 per share.
Joel Lewis serves as Executive at GALECTIN THERAPEUTICS INC (GALT). They have executed 118 insider transactions totaling $468.0K over their tenure at the company.
Joel Lewis holds the position of Executive at GALECTIN THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Joel Lewis has shown a selling trading pattern, with $79.5K in total purchases and $388.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joel Lewis was on Mar 1, 2024, when they purchased $299.1K worth of GALT shares. This transaction involved 152,584 shares at $1.96 per share.
Joel Lewis currently owns 776,260 shares of GALECTIN THERAPEUTICS INC (GALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joel Lewis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joel Lewis has 118 Form 4 filings on record as an insider at GALECTIN THERAPEUTICS INC.
Set alerts for Joel Lewis and 40,000+ other insiders.